Compare CDMOs with PMDA (Japan) GMP approval for manufacturing pharmaceuticals destined for the Japanese market. Filter by product type and manufacturing capabilities.
73 companies listed
PMDA (Pharmaceuticals and Medical Devices Agency) is Japan's pharmaceutical regulatory agency. PMDA conducts GMP inspections of manufacturing facilities producing drugs for the Japanese market. PMDA GMP compliance is required for marketing authorization in Japan -- the world's third-largest pharmaceutical market by revenue.
PMDA inspections have unique characteristics. The agency places particular emphasis on change control (every manufacturing change must be formally assessed and approved), stability testing (Japanese climate conditions may require additional data), and data integrity. CDMOs with PMDA approval demonstrate compliance with one of the most thorough regulatory inspection regimes globally.
India
CTX Life Sciences Pvt. Ltd. is a vertically integrated API and intermediate manufacturer based near Surat, Gujarat, India. The company operates a world-class manufacturing facility with a total area of 147,227 sqm, capable of handling complex and hazardous reactions, with DSIR-approved R&D and a collective reactor capacity of around 900 KL. The facility has been inspected by US FDA (6 times), EDQM, BfArM (Germany), TGA (Australia), PMDA (Japan), Health Canada, ANVISA (Brazil), and COFEPRIS (Mexico).
China
Dishman Carbogen Amcis Ltd is a global CDMO and pharmaceutical outsourcing partner with operations across India, Switzerland, UK, France, Netherlands, and China. With 30 years of experience, they offer custom API development and manufacturing up to 100 metric ton scale, drug product capabilities including highly potent compounds and ADCs, plus finished dosage forms including soft gel capsules and encapsulation. They have received successful USFDA, PMDA, and EDQM inspections.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.